Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Choosing the Right Pharmaceutical Consultants Near Corona, CA: A Step-by-Step Guide

Aug 23, 2025

Understanding the Role of Pharmaceutical Consultants

Pharmaceutical consultants play a crucial role in helping businesses navigate the complex landscape of drug development, regulatory compliance, and market strategy. These experts provide insights and guidance that can significantly influence the success of pharmaceutical projects. If you're located in or around Corona, CA, choosing the right consultant is critical to ensure your company achieves its goals effectively.

pharmaceutical consultant

Identifying Your Business Needs

Before you begin your search for a pharmaceutical consultant, it's important to clearly define what your business needs are. Whether you require assistance with regulatory affairs, clinical trials, or quality assurance, knowing your specific requirements will help you find a consultant whose expertise aligns with your objectives.

Consider creating a list of challenges your company is currently facing. This inventory will not only help you communicate your needs more effectively but also serve as a benchmark when evaluating potential consultants.

Researching Potential Consultants

Once you have a clear understanding of your needs, it's time to research potential consultants. Start by seeking recommendations from industry peers or conducting an online search for consultants specializing in your area of interest. Look for professionals with strong credentials and a proven track record of success in the pharmaceutical industry.

pharmaceutical research

Evaluating Experience and Expertise

Experience is a critical factor when choosing a pharmaceutical consultant. Review their past projects and client testimonials to gain insight into their capabilities. It's beneficial to select a consultant with extensive knowledge in the specific sector of pharmaceuticals relevant to your business, whether it be biotechnology, generics, or another area.

Additionally, consider their familiarity with the regulatory landscape in California, as local expertise can be a significant advantage.

Assessing Communication and Compatibility

Effective communication is essential for a successful consultancy relationship. During initial meetings or consultations, assess how well the consultant listens to your concerns and explains their approach. Their ability to articulate complex concepts clearly is crucial for smooth collaboration.

Ensure that their working style and values align with your company culture. Compatibility in this regard can foster a more productive and harmonious working relationship.

business meeting

Considering Cost and Contractual Terms

Cost is an important consideration when selecting a pharmaceutical consultant. Request detailed proposals from potential consultants, including pricing structures and what services are covered. Be wary of unusually low fees, as these might indicate a lack of experience or hidden costs.

Review the contractual terms carefully to ensure they align with your expectations. Pay attention to confidentiality clauses, service scope, and termination conditions to avoid any misunderstandings down the line.

Making the Final Decision

After thorough evaluation, you should have a shortlist of candidates who meet your criteria. Weigh the pros and cons of each consultant based on your research and interactions. Trust your instincts; choose a consultant who not only meets your technical requirements but also feels like the right fit for your company.

Taking these steps will help ensure that you select a pharmaceutical consultant who can provide valuable insights and support, ultimately contributing to the success of your projects.